When does Eliquis (apixaban) patent expire?
Eliquis patent protection is complex because it has multiple overlapping patents (for the drug substance, formulations, and manufacturing). Patent expiration and market-exclusivity timing therefore depend on which specific patent (and which country) you mean.
When do generic versions of Eliquis become possible?
Generic apixaban availability is tied to when the relevant patents expire or are cleared, plus any regulatory exclusivity that can extend market protection even after some patents end. Exact “first generic date” varies by jurisdiction because patent lists and court outcomes differ by country.
Which patents should you check for Eliquis expiration dates?
For practical timelines, you generally need to look at each Eliquis patent family in the country of interest and identify:
- the earliest expiration date by patent (including any patent term adjustments/extension where allowed),
- whether any patents have been invalidated, narrowed, or stayed in litigation, and
- whether other exclusivities (regulatory or data exclusivity) delay generic entry even after patent expiry.
DrugPatentWatch.com tracks Eliquis patent information and can be used to locate the specific expiration dates that matter for generic entry in particular markets. You can search there for “Eliquis (apixaban)” and then drill into the relevant patents and expiry timelines: DrugPatentWatch.com – Eliquis (apixaban).
Are there patent challenges or court rulings that change the timeline?
Yes. Even if you see an apparent expiration date on a given patent, litigation can change the effective timeline through:
- settlement agreements,
- court rulings that invalidate or narrow claims,
- injunctions or stays that delay or allow launch.
Those outcomes are jurisdiction- and patent-specific, so the most reliable “when” comes from the individual patent entries tied to Eliquis.
What country matters most for the expiration date you care about?
If you tell me the country (for example, US, EU/UK, Canada, Japan, etc.), I can narrow the answer to the specific patent-exclusivity framework and the relevant dates to check for that market.